Immune adjuvant therapy using Bacillus Calmette–Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments

The cell wall skeleton of Bacillus Calmette–Guérin (BCG-CWS) is a bioactive component that is a strong immune adjuvant for cancer immunotherapy. BCG-CWS activates the innate immune system through various pattern recognition receptors and is expected to elicit antigen-specific cellular immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishida, Sumiyuki, Tsuboi, Akihiro, Tanemura, Atsushi, Ito, Toshinori, Nakajima, Hiroko, Shirakata, Toshiaki, Morimoto, Soyoko, Fujiki, Fumihiro, Hosen, Naoki, Oji, Yusuke, Kumanogoh, Atsushi, Kawase, Ichiro, Oka, Yoshihiro, Azuma, Ichiro, Morita, Satoshi, Sugiyama, Haruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831317/
https://www.ncbi.nlm.nih.gov/pubmed/31415377
http://dx.doi.org/10.1097/MD.0000000000016771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831317/
https://www.ncbi.nlm.nih.gov/pubmed/31415377
http://dx.doi.org/10.1097/MD.0000000000016771

Ejemplares similares